Elevated serum OPN levels have been correlated with disease severity in inflammatory conditions such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), suggesting that OPN may serve as a potential biomarker for disease activity [98]. This evidence concerns the gene SPP1 and systemic lupus erythematosus.